During 2026\/07\/01 to 2026\/07\/31, 35,300 common shares were acquired via market purchases at 40,066,400 yen. The maximum plan is 430,000 shares \/ 520,000,000 yen. As of 2026\/07\/31, the total number of shares acquired is 407,900 shares, and the total amount is 468,573,200 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5187","jir_company_name":"Create Medico Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/5187-20260803-01.pdf","jir_short_summary":"During 2026\/07\/01 to 2026\/07\/31, 35,300 common shares were acquired via market purchases at 40,066,400 yen. The maximum plan is 430,000 shares \/ 520,000,000 yen. As of 2026\/07\/31, the total number of shares acquired is 407,900 shares, and the total amount is 468,573,200 yen.","jir_summary":"### Overview of the acquisition status\nOn March 27, 2026, the Board resolved to set the normal shares\u2019 share buyback limit at up to 430,000 shares and up to 520,000,000 yen to be acquired via market purchases. This notice reports the actuals: 35,300 shares acquired and 40,066,400 yen spent from July 1, 2026 to July 31, 2026. As of July 31, 2026, the cumulative total is 407,900 shares and 468,573,200 yen.\n\n### Impact on capital policy and future outlook\nThe share buyback was conducted via market purchases, and progress toward the cap since the resolution is reflected in the figures. The dilution impact and shareholder return considerations can only be judged from these figures, and additional pricing strategies or final timing of completion will be disclosed separately. Ongoing progress of future buyback plans will be an important point of focus.","jir_financial_highlights":"Total number of acquired shares: 35,300 shares (Acquired during the period)\nTotal amount acquired: 40,066,400 yen (Acquired during the period)\nAdditional acquisition cap (resolution): 430,000 shares \/ 520,000,000 yen (As of resolution)\nCumulative acquired shares as of 2026\/07\/31: 407,900 shares (Actuals up to the above period)\nCumulative acquired total as of 2026\/07\/31: 468,573,200 yen (Actuals up to the above period)","jir_category":"","jir_hashtags":"#CreateMedicoCo.,Ltd., #ShareBuyback, #JapanStocks","jir_key_figures":"Total number of acquired shares: 35,300 shares\nTotal amount acquired: 40,066,400 yen\nCumulative acquired shares as of 2026\/07\/31: 407,900 shares","jir_meta_title":"[Create Medico Co., Ltd.] Notice of Share Buyback Status | July 2026","jir_meta_description":"Summary of Create Medico Co., Ltd.'s share buyback status. Details of acquisition period, number of shares, total amount, and relation to the cap plan. Also notes prospects for additional acquisitions.","jir_og_title":"[Create Medico Co., Ltd.] Notice of Share Buyback Status | July 2026","jir_og_description":"Reporter of the number of shares and amount for the share buyback conducted in July 2026, and cumulative results. Also mentions future plans and impact on shareholders.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59045,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-93478","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n